These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3008312

  • 1. Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG.
    Dreikorn K, Doerr HW, Geursen RG.
    Scand J Urol Nephrol Suppl; 1985; 92():15-21. PubMed ID: 3008312
    [Abstract] [Full Text] [Related]

  • 2. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H, Qorashi M, Heidari A.
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [Abstract] [Full Text] [Related]

  • 3. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C.
    G Batteriol Virol Immunol; 1991 Sep; 84(1-12):41-52. PubMed ID: 1668971
    [Abstract] [Full Text] [Related]

  • 4. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM, O'Reilly RJ.
    Birth Defects Orig Artic Ser; 1984 Sep; 20(1):327-44. PubMed ID: 6329370
    [No Abstract] [Full Text] [Related]

  • 5. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
    Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Bacigalupo A.
    Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
    [Abstract] [Full Text] [Related]

  • 6. Does intravenous immunoglobulin prevent primary cytomegalovirus disease in kidney transplant recipients?
    Khawand N, Light JA, Brems W, Aquino A, Ali A.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2072-4. PubMed ID: 2540555
    [No Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
    Peterson PK, Balfour HH, Marker SC, Fryd DS, Howard RJ, Simmons RL.
    Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
    [Abstract] [Full Text] [Related]

  • 8. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
    Ruutu T, Ljungman P, Brinch L, Lenhoff S, Lönnqvist B, Ringdén O, Ruutu P, Volin L, Albrechtsen D, Sallerfors B, Ebeling F, Myllylä G.
    Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
    [Abstract] [Full Text] [Related]

  • 9. Polyvalent immune globulin and cytomegalovirus infection after renal transplantation.
    Kasiske BL, Heim-Duthoy KL, Tortorice KL, Ney AL, Odland MD, Rao KV.
    Arch Intern Med; 1989 Dec; 149(12):2733-6. PubMed ID: 2556978
    [Abstract] [Full Text] [Related]

  • 10. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K.
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [Abstract] [Full Text] [Related]

  • 11. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G, Chaushu S, Slavin S, Or R, Garfunkel AA, Yefenof E.
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.
    Reusser P, Osterwalder B, Gratama JW, The TH, Gratwohl A, Speck B.
    Bone Marrow Transplant; 1989 May; 4(3):267-72. PubMed ID: 2543469
    [Abstract] [Full Text] [Related]

  • 13. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W.
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [Abstract] [Full Text] [Related]

  • 14. [Detection of cytomegalovirus antibody levels in renal transplant patients by complement fixation and ELISA tests].
    Saify SJ, Ustaçelebi S, Haberal M.
    Mikrobiyol Bul; 1986 Oct; 20(4):256-65. PubMed ID: 2821363
    [Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus antibodies in renal transplant recipients.
    Jankowski M, Gut W, Nawrocka E, Gradowska L, Roncewicz Z, Rowińska D.
    Acta Microbiol Pol; 1982 Oct; 31(3-4):279-85. PubMed ID: 6189377
    [Abstract] [Full Text] [Related]

  • 16. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK, Peiris JS, Taylor CE, Warwicker P, Jarrett RF, Madeley CR.
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [Abstract] [Full Text] [Related]

  • 17. Prophylaxis of CMV infection in bone marrow transplant recipients by hyperimmune CMV gamma-globulin.
    Condie RM, O'Reilly RJ.
    Dev Biol Stand; 1982 Apr; 52():501-13. PubMed ID: 6299859
    [Abstract] [Full Text] [Related]

  • 18. [Prevalence of antibodies against herpes simplex virus, Epstein-Barr virus and cytomegalovirus in a group of patients after hemodialysis].
    Resik S, Enamorado A, Tallo Y, Suárez C, Kourí V, Acosta B, García S.
    Rev Cubana Med Trop; 1999 Apr; 51(3):172-6. PubMed ID: 10887583
    [Abstract] [Full Text] [Related]

  • 19. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E, Suter F, Baruzzo S, Perani V, Moioli F, Remuzzi G.
    Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [Abstract] [Full Text] [Related]

  • 20. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M, Styczyński P.
    Arch Immunol Ther Exp (Warsz); 1987 Dec; 35(3):313-9. PubMed ID: 2833198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.